Mexico Hemostats Market Size, Share & COVID-19 Impact Analysis, By Product (Active {Thrombin based, and Fibrin Sealants}, Passive {Plant Based, Animal-Based, and Others}, Combination Hemostats, and Others); By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, and Others); By End-User (Hospitals & ASCs, Tactical Combat Casualty Care Centers, and Others), and Forecast, 2021-2028

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI106189

THANK YOU

FOR YOUR INTEREST IN OUR REPORT

Are you interested in exploring our consulting services?

I want to learn more about:

Competitive Intelligence Opportunity Assessment Distribution & Supply Chain Analysis Book a consultation to discuss your needs

Market Entry Strategy Go-to-market Strategy Others (Please specify)

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Epidemiology of Key Diseases, in Mexico, 2020
2. Key Industry Developments - Mergers, Acquisitions, and Partnerships
3. New Product Launches
4. Impact of COVID-19 on the Market
Mexico Hemostats Market Analysis, Insights and Forecast, 2017-2028
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product
  1. Active Hemostats
    1. Thrombin-based Hemostats
    2. Fibrin Sealants
  2. Passive Hemostats
    1. Plant-based Hemostats
    2. Animal-based Hemostats
    3. Others
  3. Combination Hemostats
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Trauma
  2. Cardiovascular Surgery
  3. General Surgery
  4. Plastic Surgery
  5. Orthopaedic Surgery
  6. Neurosurgery
  7. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & ASCs
  2. Tactical Combat Casualty Care Centers
  3. Others
Competitive Analysis
1. Mexico Market Share Analysis (2020)
2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
  1. Baxter
    1. Overview,
    2. Products,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  2. CryoLife, Inc.
    1. Overview,
    2. Products,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  3. CryoLife Inc.
    1. Overview,
    2. Products,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  4. BD
    1. Overview,
    2. Products,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  5. Johnson & Johnson Services, Inc.
    1. Overview,
    2. Products,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  6. Cook
    1. Overview,
    2. Products,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  7. Dorian Drake International Inc.
    1. Overview,
    2. Products,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  8. 3-D Matrix Medical Technology
    1. Overview,
    2. Products,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  9. EndoClot Plus, Inc.
    1. Overview,
    2. Products,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  10. Other Players
    1. Overview,
    2. Products,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)